DiaSorin
Italian biotechnoloty company
DSRNY OTC
ISIN IT0003492391 LEI 8156002878BDF0EE4348
Follow DiaSorin
Weekly email: filings, results
Revenue, last year
€1.2B
+0.8% vs prior year
Net income
€155.6M
−17.3% vs prior year
EPS, diluted
€2.85
−14.9% vs prior year
Operating cash flow
€342.8M
−4.5% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | €1.2B | €155.6M |
| FY24 | €1.2B | €188.1M |
| FY23 | €1.1B | €159.8M |
| FY22 | €1.4B | €240.9M |
| FY21 | €1.2B | €311M |
| FY20 | €881.3M | €247.9M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 64.7% | 19.1% | 13% |
| FY24 | 65.9% | 21.8% | 15.9% |
| FY23 | 64.6% | 18.8% | 13.9% |
| FY22 | 66.2% | 25.8% | 17.7% |
| FY21 | 66.6% | 33.9% | 25.1% |
| FY20 | 68.4% | 36.8% | 28.1% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | €281M |
| FY24 | €306.7M |
| FY23 | €266.2M |
| FY22 | €336.1M |
| FY21 | €332.2M |
| FY20 | €262.1M |
Show the numbers
| Year | Dividends |
|---|---|
| FY25 | €63.5M |
| FY24 | €61.3M |
| FY23 | €59M |
| FY22 | €57.1M |
| FY21 | €54.7M |
| FY20 | €52.1M |
- DiaSorin
- Healthcare median
Show the numbers
| Year | DiaSorin | Healthcare median |
|---|---|---|
| FY25 | 13% | −30.6% |
| FY24 | 15.9% | −47% |
| FY23 | 13.9% | −58% |
| FY22 | 17.7% | −80.4% |
| FY21 | 25.1% | −71.9% |
| FY20 | 28.1% | −62.2% |